Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical College: Hospital for Special Surgery - Rheumatology Division
2262
mi
from 98109
New York, NY
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical College: Hospital for Special Surgery - Rheumatology Division
2262
mi
from 98109
New York, NY
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Ohio State University
2006
mi
from 98109
Columbus, OH
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Ohio State University
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Oklahoma Medical Research Foundation
1523
mi
from 98109
Oklahoma City, OK
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Oklahoma Medical Research Foundation
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
Penn State University
2294
mi
from 98109
Hershey, PA
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
Penn State University
2294
mi
from 98109
Hershey, PA
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
University of Colorado
1023
mi
from 98109
Denver, CO
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
University of Colorado
1023
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
New York University Langone Medical Center
2402
mi
from 98109
New York, NY
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
New York University Langone Medical Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/31/1969
University of Mississippi Medical Center
1983
mi
from 98109
Jackson, MS
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/31/1969
University of Mississippi Medical Center
1983
mi
from 98109
Jackson, MS
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
(AOA) Arthritis & Osteoporosis Associates
2404
mi
from 98109
Freehold, NJ
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
(AOA) Arthritis & Osteoporosis Associates
2404
mi
from 98109
Freehold, NJ
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Advanced Pharma Clinical Research
2724
mi
from 98109
Miami, FL
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Advanced Pharma Clinical Research
2724
mi
from 98109
Miami, FL
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Albuquerque Clinical Trials
1184
mi
from 98109
Albuquerque, NM
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Albuquerque Clinical Trials
1184
mi
from 98109
Albuquerque, NM
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Altoona Center for Clinical Research
2206
mi
from 98109
Duncansville, PA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Altoona Center for Clinical Research
2206
mi
from 98109
Duncansville, PA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Arthritis Northwest Rheumatology
228
mi
from 98109
Spokane, WA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Arthritis Northwest Rheumatology
228
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Arthritis Research of Florida, Inc.
2508
mi
from 98109
Palm Harbor, FL
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Arthritis Research of Florida, Inc.
2508
mi
from 98109
Palm Harbor, FL
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Box Arthritis and Rheumatology of the Carolina's
2281
mi
from 98109
Charlotte, NC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Box Arthritis and Rheumatology of the Carolina's
2281
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center of Reading, LLP
2323
mi
from 98109
Wyomissing, PA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center of Reading, LLP
2323
mi
from 98109
Wyomissing, PA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Clinical Research of West Florida, Inc.
2523
mi
from 98109
Tampa, FL
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Clinical Research of West Florida, Inc.
2523
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Denver Arthritis Center
1025
mi
from 98109
Denver, CO
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Denver Arthritis Center
1025
mi
from 98109
Denver, CO
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Desert Medical Advances
1010
mi
from 98109
Palm Desert, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Desert Medical Advances
1010
mi
from 98109
Palm Desert, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Indiana University Health
1868
mi
from 98109
Indianapolis, IN
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Indiana University Health
1868
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Inlande Rheumatology Clinical Trials
965
mi
from 98109
Upland, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Inlande Rheumatology Clinical Trials
965
mi
from 98109
Upland, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Innovative Health Research
868
mi
from 98109
Las Vegas, NV
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Innovative Health Research
868
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Low Country Research Center
2412
mi
from 98109
North Charleston, SC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Low Country Research Center
2412
mi
from 98109
North Charleston, SC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Medvin Clinical Research
964
mi
from 98109
Covina, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Medvin Clinical Research
964
mi
from 98109
Covina, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
New England Research Associates, Llc
2421
mi
from 98109
Trumbull, CT
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
New England Research Associates, Llc
2421
mi
from 98109
Trumbull, CT
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
New Horizon Research Center
2732
mi
from 98109
Miami, FL
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
New Horizon Research Center
2732
mi
from 98109
Miami, FL
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Oklahoma Arthritis Center
1516
mi
from 98109
Edmond, OK
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Oklahoma Arthritis Center
1516
mi
from 98109
Edmond, OK
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Paramount Medical Research
2019
mi
from 98109
Middleburg Heights, OH
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Paramount Medical Research
2019
mi
from 98109
Middleburg Heights, OH
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Pharmquest
2295
mi
from 98109
Greensboro, NC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Pharmquest
2295
mi
from 98109
Greensboro, NC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Physician Research Collaboration
1346
mi
from 98109
Lincoln, NE
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Physician Research Collaboration
1346
mi
from 98109
Lincoln, NE
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Pmg Research Of Salisbury
2281
mi
from 98109
Salisbury, NC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Pmg Research Of Salisbury
2281
mi
from 98109
Salisbury, NC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
ProHealth Partners Medical Group
979
mi
from 98109
Long Beach, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
ProHealth Partners Medical Group
979
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Shanahan Rheumatology and Immunotherapy, PLLC
2361
mi
from 98109
Raleigh, NC
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Shanahan Rheumatology and Immunotherapy, PLLC
2361
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Sun Research Institute
1786
mi
from 98109
San Antonio, TX
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Sun Research Institute
1786
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Tekton Research
1770
mi
from 98109
Austin, TX
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Tekton Research
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Arthritis and Diabetes Clinic, Inc
1891
mi
from 98109
Monroe, LA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Arthritis and Diabetes Clinic, Inc
1891
mi
from 98109
Monroe, LA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
The Feinstein Institute for Medical Research
2413
mi
from 98109
Manhasset, NY
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
The Feinstein Institute for Medical Research
2413
mi
from 98109
Manhasset, NY
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Virginia Clinical Research, Inc.
2429
mi
from 98109
Norfolk, VA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Virginia Clinical Research, Inc.
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Wallace Rheumatic Study Center
959
mi
from 98109
Los Angeles, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Wallace Rheumatic Study Center
959
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
West Michigan Rheumatology
1802
mi
from 98109
Grand Rapids, MI
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
West Michigan Rheumatology
1802
mi
from 98109
Grand Rapids, MI
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Westroads Clinical Research - Omaha
1366
mi
from 98109
Omaha, NE
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Westroads Clinical Research - Omaha
1366
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 98109
Daejeon,
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 98109
Daejeon,
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
TriWest Research Associates, LLC
1062
mi
from 98109
El Cajon, CA
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
TriWest Research Associates, LLC
1062
mi
from 98109
El Cajon, CA
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Clayton Medical Research
1714
mi
from 98109
Saint Louis, MO
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Clayton Medical Research
1714
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/31/1969
Mountain State Clinical Research
2155
mi
from 98109
Clarksburg, WV
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/31/1969
Mountain State Clinical Research
2155
mi
from 98109
Clarksburg, WV
Click here to add this to my saved trials
Nelfinavir in Systemic Lupus Erythematosus
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
962
mi
from 98109
Los Angeles, CA
Nelfinavir in Systemic Lupus Erythematosus
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Nelfinavir in Systemic Lupus Erythematosus
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Status: Enrolling
Updated:  12/31/1969
UCLA David Geffen School of Medicine
962
mi
from 98109
Los Angeles, CA
Nelfinavir in Systemic Lupus Erythematosus
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Status: Enrolling
Updated: 12/31/1969
UCLA David Geffen School of Medicine
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials